Health authorities in South Africa announced Tuesday they were putting a pause on the single-shot Johnson & Johnson COVID-19 vaccine after six recipients, out of nearly 7 million total in the US, experienced rare blood clots. Host Carol Hills speaks with Mosa Moshabela, professor of public health at the University of KwaZulu-Natal, from Durban.
The story you just read is available for free because thousands of listeners and readers like you generously support our nonprofit newsroom. Every day, reporters and producers at The World are hard at work bringing you human-centered news from across the globe. But we can’t do it without you: We need your support to ensure we can continue this work for another year.
Make a gift today, and you’ll get us one step closer to our goal of raising $25,000 by June 14. We need your help now more than ever!